MEDCAPTAIN (02041.HK): Grey-market opens18.5% lower at HKD 12.59

NewTimeSpace News: Shenzhen Medcaptain Bio-Medical Technology Co., Ltd. (stock code: 02041) conducted grey-market trading on 4 September 2026, opening18.5% lower at HKD 12.59. The Company expects its H shares to begin trading on the Main Board of the Hong Kong Stock Exchange at 9:00 a.m. on Monday, 7 September 2026.

Founded in 2011 in Shenzhen, Guangdong Province, the Company is a global medical device provider with three business segments: life support, minimally invasive intervention, and in-vitro diagnostics, meeting the clinical needs of clinical departments, wards and clinics within medical institutions, as well as community health centres, testing institutions and home care scenarios. As of 31 March 2026, the Company's product portfolio included over 60 life support products, 110 minimally invasive intervention products and 150 in-vitro diagnostic products. During the track record period, the Company strategically established five R&D centres and six production centres in China and the United Kingdom.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.